Bristol Myers Squibb is dedicated to conscientious corporate citizenship, aiming to make a positive difference globally. They are focused on supporting efforts that help patients and their families, improve healthcare, and advance scientific understanding, while also contributing to building strong communities.
The Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA) focuses on expanding diversity in clinical trials, addressing the underrepresentation of certain communities in this crucial research area. This program is a two-year initiative designed to support early-stage investigator physicians from diverse backgrounds, as well as those committed to enhancing diversity in clinical research. The goal is for these individuals to become independent clinical trial investigators who contribute to health equity through their research and mentoring. The Winn CDA emphasizes the importance of diverse clinical trial participation to improve healthcare for all, by ensuring new medicines are tested across varied populations. Recipients of the Winn CDA receive annual funding, mentorship, and are involved in existing clinical trials to build their experience, focusing on areas like cancer, cardiovascular disease, and immunologic disorders.